Global Gene Therapy Market Size study & Forecast, by Vector [Viral VectorsNon-viral VectorsBy Delivery Method (In Vivo, Ex Vivo) by Application (Oncological Disorders, Rare Diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Diseases, Others), By Gene Type (Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Receptors, Others), and Regional Analysis, 2022-2029
Global Gene Therapy Market is valued at approximately USD 6.2 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 18.6% over the forecast period 2021-2029. An instruction set for a certain function is carried by a gene, a functional hereditary unit of life. The most cutting-edge treatment for blood disorders, chronic illnesses, infectious diseases, and cancer is gene therapy. The term 'gene therapy' refers to the process of treating a disease by altering, substituting, or enhancing a missing or deficient genetic combination that causes the ailment. To treat or stop the spread of disease, gene therapy entails replacing some or all of a patient's body's damaged genes with healthy ones. Globally rising rates of cancer, uncommon diseases, genetic disorders, and other medical conditions are the major factors fueling the growth of the gene therapy market.
Over the past few years, gene therapy research has gained more attention. Many businesses introduce cutting-edge products to capitalize on market growth prospects. A researcher from the Indiana University School of Medicine received a USD 12 million grant from the national heart, lung, and blood institute in March 2022. The grant will be used to investigate key ideas in a gene therapy strategy for more effective and potentially curative hemophilia therapies. A robust product portfolio, increasing investments by major market participants, a high prevalence of the target diseases, and interest in novel and creative therapies are some factors that affect the growth of the gene therapy industry. In developed nations, sophisticated therapeutic approaches to chronic disorders are being applied. As a result, chemotherapy and other conventional treatment modalities that have unfavorable side effects and long-term consequences are being substituted with this one. Viral vectors, which have low toxicity and high immunogenicity, are increasingly being used in the production of such medications.The high cost of gene treatments, however, is anticipated to somewhat restrain market expansion throughout the forecast period.
The key regions considered for the Global Gene Therapy Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America segment dominated the global gene therapy market in 2020, in terms of revenue, and is estimated to maintain its dominance during the forecast period. Several government organizations are supporting research campaigns around the country, owing to the robust regulatory framework for cellular treatment development and the substantial presence of biopharmaceutical businesses. Europe is expected to grow with the highest CAGR during the forecast period, the availability of reimbursements, the presence of key industry players in the area, and the existence of contemporary healthcare infrastructure are all essential factors promoting the expansion of the gene therapy market in Europe.
Major market player included in this report are:
Amgen Inc.
Biogen Inc.
Bluebird Bio Inc.
Gilead Sciences Inc. (Kite Pharma)
Novartis AG
Orchard Therapeutics
Sibiono GeneTech Co. Ltd
Hoffmann-La Roche Ltd (Spark Therapeutics)
UniQure NV
Abeona Therapeutics Inc.
Recent Developments in the Market:
Sarepta Therapeutics (US) established a partnership with GenEdit in February 2022 to create gene-editing therapeutics to treat neuromuscular illnesses using Sarepta's technology and GenEdit's NanoGalaxy platform.
The FDA approved KYMRIAH for adult patients with relapsed or refractory follicular lymphoma after two or more lines of systemic therapy in May 2022 from Novartis AG (Switzerland).
Global Gene Therapy Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered vectors, Delivery Method, Application, Gene Type, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Vectors:
Viral Vectors
Non-viral Vectors
By Delivery Method:
In Vivo
Ex Vivo
By Application:
Oncological Disorders
Rare Diseases
Cardiovascular Diseases
Neurological Disorders
Infectious Diseases
Others
By Gene Type:
Antigen
Cytokine
Tumor Suppressor
Suicide
Deficiency
Receptors
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
South Korea
RoAPAC
Rest of the World
Over the past few years, gene therapy research has gained more attention. Many businesses introduce cutting-edge products to capitalize on market growth prospects. A researcher from the Indiana University School of Medicine received a USD 12 million grant from the national heart, lung, and blood institute in March 2022. The grant will be used to investigate key ideas in a gene therapy strategy for more effective and potentially curative hemophilia therapies. A robust product portfolio, increasing investments by major market participants, a high prevalence of the target diseases, and interest in novel and creative therapies are some factors that affect the growth of the gene therapy industry. In developed nations, sophisticated therapeutic approaches to chronic disorders are being applied. As a result, chemotherapy and other conventional treatment modalities that have unfavorable side effects and long-term consequences are being substituted with this one. Viral vectors, which have low toxicity and high immunogenicity, are increasingly being used in the production of such medications.The high cost of gene treatments, however, is anticipated to somewhat restrain market expansion throughout the forecast period.
The key regions considered for the Global Gene Therapy Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America segment dominated the global gene therapy market in 2020, in terms of revenue, and is estimated to maintain its dominance during the forecast period. Several government organizations are supporting research campaigns around the country, owing to the robust regulatory framework for cellular treatment development and the substantial presence of biopharmaceutical businesses. Europe is expected to grow with the highest CAGR during the forecast period, the availability of reimbursements, the presence of key industry players in the area, and the existence of contemporary healthcare infrastructure are all essential factors promoting the expansion of the gene therapy market in Europe.
Major market player included in this report are:
Amgen Inc.
Biogen Inc.
Bluebird Bio Inc.
Gilead Sciences Inc. (Kite Pharma)
Novartis AG
Orchard Therapeutics
Sibiono GeneTech Co. Ltd
Hoffmann-La Roche Ltd (Spark Therapeutics)
UniQure NV
Abeona Therapeutics Inc.
Recent Developments in the Market:
Sarepta Therapeutics (US) established a partnership with GenEdit in February 2022 to create gene-editing therapeutics to treat neuromuscular illnesses using Sarepta's technology and GenEdit's NanoGalaxy platform.
The FDA approved KYMRIAH for adult patients with relapsed or refractory follicular lymphoma after two or more lines of systemic therapy in May 2022 from Novartis AG (Switzerland).
Global Gene Therapy Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered vectors, Delivery Method, Application, Gene Type, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Vectors:
Viral Vectors
Non-viral Vectors
By Delivery Method:
In Vivo
Ex Vivo
By Application:
Oncological Disorders
Rare Diseases
Cardiovascular Diseases
Neurological Disorders
Infectious Diseases
Others
By Gene Type:
Antigen
Cytokine
Tumor Suppressor
Suicide
Deficiency
Receptors
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
South Korea
RoAPAC
Rest of the World
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Gene Therapy Market, by Region, 2019-2029 (USD Billion)
1.2.2. Gene Therapy Market, by vector, 2019-2029 (USD Billion)
1.2.3. Gene Therapy Market, by Delivery Method, 2019-2029 (USD Billion)
1.2.4. Gene Therapy Market, by Application, 2019-2029 (USD Billion)
1.2.5. Gene Therapy Market, by Gene Type, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL GENE THERAPY MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL GENE THERAPY MARKET DYNAMICS
3.1. Gene Therapy Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Globally rising rates of Cancer and Genetic Diseases
3.1.1.2. Increasing Investment by major Market Players
3.1.2. Market Challenges
3.1.2.1. High Cost of Gene Therapy
3.1.3. Market Opportunities
3.1.3.1. Research and Development of Gene Therapy
CHAPTER 4. GLOBAL GENE THERAPY MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL GENE THERAPY MARKET, BY VECTOR
6.1. Market Snapshot
6.2. Global Gene Therapy Market by vector, Performance - Potential Analysis
6.3. Global Gene Therapy Market Estimates & Forecasts by vector 2019-2029 (USD Billion)
6.4. Gene Therapy Market, Sub Segment Analysis
6.4.1. Viral Vectors
6.4.2. Non-viral Vectors
CHAPTER 7. GLOBAL GENE THERAPY MARKET, BY DELIVERY METHOD
7.1. Market Snapshot
7.2. Global Gene Therapy Market by Delivery Method, Performance - Potential Analysis
7.3. Global Gene Therapy Market Estimates & Forecasts by Delivery Method 2019-2029 (USD Billion)
7.4. Gene Therapy Market, Sub Segment Analysis
7.4.1. In Vivo
7.4.2. Ex Vivo
CHAPTER 8. GLOBAL GENE THERAPY MARKET, BY APPLICATION
8.1. Market Snapshot
8.2. Global Gene Therapy Market by Application, Performance - Potential Analysis
8.3. Global Gene Therapy Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
8.4. Gene Therapy Market, Sub Segment Analysis
8.4.1. Oncological Disorders
8.4.2. Rare Diseases
8.4.3. Cardiovascular Diseases
8.4.4. Neurological Disorders
8.4.5. Infectious Diseases
8.4.6. Others
CHAPTER 9. GLOBAL GENE THERAPY MARKET, BY GENE TYPE
9.1. Market Snapshot
9.2. Global Gene Therapy Market by Gene Type, Performance - Potential Analysis
9.3. Global Gene Therapy Market Estimates & Forecasts by Gene Type 2019-2029 (USD Billion)
9.4. Gene Therapy Market, Sub Segment Analysis
9.4.1. Antigen
9.4.2. Cytokine
9.4.3. Tumor Suppressor
9.4.4. Suicide
9.4.5. Deficiency
9.4.6. Receptors
9.4.7. Others
CHAPTER 10. GLOBAL GENE THERAPY MARKET, REGIONAL ANALYSIS
10.1. Gene Therapy Market, Regional Market Snapshot
10.2. North America Gene Therapy Market
10.2.1. U.S. Gene Therapy Market
10.2.1.1. vector breakdown estimates & forecasts, 2019-2029
10.2.1.2. Delivery Method breakdown estimates & forecasts, 2019-2029
10.2.1.3. Application breakdown estimates & forecasts, 2019-2029
10.2.1.4. Gene Type breakdown estimates & forecasts, 2019-2029
10.2.2. Canada Gene Therapy Market
10.3. Europe Gene Therapy Market Snapshot
10.3.1. U.K. Gene Therapy Market
10.3.2. Germany Gene Therapy Market
10.3.3. France Gene Therapy Market
10.3.4. Spain Gene Therapy Market
10.3.5. Italy Gene Therapy Market
10.3.6. Rest of Europe Gene Therapy Market
10.4. Asia-Pacific Gene Therapy Market Snapshot
10.4.1. China Gene Therapy Market
10.4.2. India Gene Therapy Market
10.4.3. Japan Gene Therapy Market
10.4.4. Australia Gene Therapy Market
10.4.5. South Korea Gene Therapy Market
10.4.6. Rest of Asia Pacific Gene Therapy Market
10.5. Latin America Gene Therapy Market Snapshot
10.5.1. Brazil Gene Therapy Market
10.5.2. Mexico Gene Therapy Market
10.6. Rest of The World Gene Therapy Market
CHAPTER 11. COMPETITIVE INTELLIGENCE
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Amgen Inc.
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. Biogen Inc.
11.2.3. Bluebird Bio Inc.
11.2.4. Gilead Sciences Inc. (Kite Pharma)
11.2.5. Novartis AG
11.2.6. Orchard Therapeutics
11.2.7. Sibiono GeneTech Co. Ltd
11.2.8. Hoffmann-La Roche Ltd (Spark Therapeutics)
11.2.9. UniQure NV
11.2.10. Abeona Therapeutics Inc
CHAPTER 12. RESEARCH PROCESS
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Gene Therapy Market, by Region, 2019-2029 (USD Billion)
1.2.2. Gene Therapy Market, by vector, 2019-2029 (USD Billion)
1.2.3. Gene Therapy Market, by Delivery Method, 2019-2029 (USD Billion)
1.2.4. Gene Therapy Market, by Application, 2019-2029 (USD Billion)
1.2.5. Gene Therapy Market, by Gene Type, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL GENE THERAPY MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL GENE THERAPY MARKET DYNAMICS
3.1. Gene Therapy Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Globally rising rates of Cancer and Genetic Diseases
3.1.1.2. Increasing Investment by major Market Players
3.1.2. Market Challenges
3.1.2.1. High Cost of Gene Therapy
3.1.3. Market Opportunities
3.1.3.1. Research and Development of Gene Therapy
CHAPTER 4. GLOBAL GENE THERAPY MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL GENE THERAPY MARKET, BY VECTOR
6.1. Market Snapshot
6.2. Global Gene Therapy Market by vector, Performance - Potential Analysis
6.3. Global Gene Therapy Market Estimates & Forecasts by vector 2019-2029 (USD Billion)
6.4. Gene Therapy Market, Sub Segment Analysis
6.4.1. Viral Vectors
6.4.2. Non-viral Vectors
CHAPTER 7. GLOBAL GENE THERAPY MARKET, BY DELIVERY METHOD
7.1. Market Snapshot
7.2. Global Gene Therapy Market by Delivery Method, Performance - Potential Analysis
7.3. Global Gene Therapy Market Estimates & Forecasts by Delivery Method 2019-2029 (USD Billion)
7.4. Gene Therapy Market, Sub Segment Analysis
7.4.1. In Vivo
7.4.2. Ex Vivo
CHAPTER 8. GLOBAL GENE THERAPY MARKET, BY APPLICATION
8.1. Market Snapshot
8.2. Global Gene Therapy Market by Application, Performance - Potential Analysis
8.3. Global Gene Therapy Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
8.4. Gene Therapy Market, Sub Segment Analysis
8.4.1. Oncological Disorders
8.4.2. Rare Diseases
8.4.3. Cardiovascular Diseases
8.4.4. Neurological Disorders
8.4.5. Infectious Diseases
8.4.6. Others
CHAPTER 9. GLOBAL GENE THERAPY MARKET, BY GENE TYPE
9.1. Market Snapshot
9.2. Global Gene Therapy Market by Gene Type, Performance - Potential Analysis
9.3. Global Gene Therapy Market Estimates & Forecasts by Gene Type 2019-2029 (USD Billion)
9.4. Gene Therapy Market, Sub Segment Analysis
9.4.1. Antigen
9.4.2. Cytokine
9.4.3. Tumor Suppressor
9.4.4. Suicide
9.4.5. Deficiency
9.4.6. Receptors
9.4.7. Others
CHAPTER 10. GLOBAL GENE THERAPY MARKET, REGIONAL ANALYSIS
10.1. Gene Therapy Market, Regional Market Snapshot
10.2. North America Gene Therapy Market
10.2.1. U.S. Gene Therapy Market
10.2.1.1. vector breakdown estimates & forecasts, 2019-2029
10.2.1.2. Delivery Method breakdown estimates & forecasts, 2019-2029
10.2.1.3. Application breakdown estimates & forecasts, 2019-2029
10.2.1.4. Gene Type breakdown estimates & forecasts, 2019-2029
10.2.2. Canada Gene Therapy Market
10.3. Europe Gene Therapy Market Snapshot
10.3.1. U.K. Gene Therapy Market
10.3.2. Germany Gene Therapy Market
10.3.3. France Gene Therapy Market
10.3.4. Spain Gene Therapy Market
10.3.5. Italy Gene Therapy Market
10.3.6. Rest of Europe Gene Therapy Market
10.4. Asia-Pacific Gene Therapy Market Snapshot
10.4.1. China Gene Therapy Market
10.4.2. India Gene Therapy Market
10.4.3. Japan Gene Therapy Market
10.4.4. Australia Gene Therapy Market
10.4.5. South Korea Gene Therapy Market
10.4.6. Rest of Asia Pacific Gene Therapy Market
10.5. Latin America Gene Therapy Market Snapshot
10.5.1. Brazil Gene Therapy Market
10.5.2. Mexico Gene Therapy Market
10.6. Rest of The World Gene Therapy Market
CHAPTER 11. COMPETITIVE INTELLIGENCE
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Amgen Inc.
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. Biogen Inc.
11.2.3. Bluebird Bio Inc.
11.2.4. Gilead Sciences Inc. (Kite Pharma)
11.2.5. Novartis AG
11.2.6. Orchard Therapeutics
11.2.7. Sibiono GeneTech Co. Ltd
11.2.8. Hoffmann-La Roche Ltd (Spark Therapeutics)
11.2.9. UniQure NV
11.2.10. Abeona Therapeutics Inc
CHAPTER 12. RESEARCH PROCESS
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Gene Therapy Market, report scope
TABLE 2. Global Gene Therapy Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Gene Therapy Market estimates & forecasts by vector 2019-2029 (USD Billion)
TABLE 4. Global Gene Therapy Market estimates & forecasts by Delivery Method 2019-2029 (USD Billion)
TABLE 5. Global Gene Therapy Market estimates & forecasts by Application 2019-2029 (USD Billion)
TABLE 6. Global Gene Therapy Market estimates & forecasts by Gene Type 2019-2029 (USD Billion)
TABLE 7. Global Gene Therapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Gene Therapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Gene Therapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Gene Therapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Gene Therapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Gene Therapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Gene Therapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Gene Therapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Gene Therapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. Global Gene Therapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 18. U.S. Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. U.S. Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 21. Canada Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. Canada Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 24. UK Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. UK Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 27. Germany Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. Germany Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 30. France Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. France Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 33. Italy Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Italy Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 36. Spain Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. Spain Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 39. RoE Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. RoE Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 42. China Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. China Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 45. India Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. India Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 48. Japan Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. Japan Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 51. South Korea Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. South Korea Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 54. Australia Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. Australia Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 57. RoAPAC Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. RoAPAC Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 60. Brazil Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Brazil Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 63. Mexico Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. Mexico Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 66. RoLA Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. RoLA Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 69. Row Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. Row Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 71. List of secondary sources, used in the study of global Gene Therapy Market
TABLE 72. List of primary sources, used in the study of global Gene Therapy Market
TABLE 73. Years considered for the study
TABLE 74. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Gene Therapy Market, report scope
TABLE 2. Global Gene Therapy Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Gene Therapy Market estimates & forecasts by vector 2019-2029 (USD Billion)
TABLE 4. Global Gene Therapy Market estimates & forecasts by Delivery Method 2019-2029 (USD Billion)
TABLE 5. Global Gene Therapy Market estimates & forecasts by Application 2019-2029 (USD Billion)
TABLE 6. Global Gene Therapy Market estimates & forecasts by Gene Type 2019-2029 (USD Billion)
TABLE 7. Global Gene Therapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Gene Therapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Gene Therapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Gene Therapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Gene Therapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Gene Therapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Gene Therapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Gene Therapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Gene Therapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. Global Gene Therapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 18. U.S. Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. U.S. Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 21. Canada Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. Canada Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 24. UK Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. UK Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 27. Germany Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. Germany Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 30. France Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. France Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 33. Italy Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Italy Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 36. Spain Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. Spain Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 39. RoE Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. RoE Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 42. China Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. China Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 45. India Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. India Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 48. Japan Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. Japan Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 51. South Korea Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. South Korea Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 54. Australia Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. Australia Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 57. RoAPAC Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. RoAPAC Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 60. Brazil Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Brazil Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 63. Mexico Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. Mexico Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 66. RoLA Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. RoLA Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 69. Row Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. Row Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 71. List of secondary sources, used in the study of global Gene Therapy Market
TABLE 72. List of primary sources, used in the study of global Gene Therapy Market
TABLE 73. Years considered for the study
TABLE 74. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Gene Therapy Market, research methodology
FIG 2. Global Gene Therapy Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Gene Therapy Market, key trends 2021
FIG 5. Global Gene Therapy Market, growth prospects 2022-2029
FIG 6. Global Gene Therapy Market, porters 5 force model
FIG 7. Global Gene Therapy Market, pest analysis
FIG 8. Global Gene Therapy Market, value chain analysis
FIG 9. Global Gene Therapy Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Gene Therapy Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Gene Therapy Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Gene Therapy Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Gene Therapy Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Gene Therapy Market, regional snapshot 2019 & 2029
FIG 15. North America Gene Therapy Market 2019 & 2029 (USD Billion)
FIG 16. Europe Gene Therapy Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Gene Therapy Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Gene Therapy Market 2019 & 2029 (USD Billion)
FIG 19. Global Gene Therapy Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Gene Therapy Market, research methodology
FIG 2. Global Gene Therapy Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Gene Therapy Market, key trends 2021
FIG 5. Global Gene Therapy Market, growth prospects 2022-2029
FIG 6. Global Gene Therapy Market, porters 5 force model
FIG 7. Global Gene Therapy Market, pest analysis
FIG 8. Global Gene Therapy Market, value chain analysis
FIG 9. Global Gene Therapy Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Gene Therapy Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Gene Therapy Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Gene Therapy Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Gene Therapy Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Gene Therapy Market, regional snapshot 2019 & 2029
FIG 15. North America Gene Therapy Market 2019 & 2029 (USD Billion)
FIG 16. Europe Gene Therapy Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Gene Therapy Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Gene Therapy Market 2019 & 2029 (USD Billion)
FIG 19. Global Gene Therapy Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
